We demonstrated increased CD3+CD4+CD26− T‐cells in CHL and increased variability in CD7 expression among T‐cell lymphoproliferative disorders relative to non‐neoplastic T‐cells. This evidence concerns the gene CD7 and classic Hodgkin lymphoma.